Skip to main content
SpringerLink
Log in

Blistering Diseases – Pemphigoid

  • Chapter
  • First Online:
Genomics, Personalized Medicine and Oral Disease

  • 821 Accesses

Abstract

This chapter contains current information on autoimmune blistering diseases that involve the skin and mucous membranes. It does not contain diseases that do not have a proven or presumed autoimmune basis. It also does not contain diseases that are genetic or genetically based.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

BP:

Bullous pemphigous

MMP:

Mucous membrane pemphigoid

LABD:

Linear IgA bullous disease

EBA:

Epidermolysis bullosa aquista

PG:

Pemphigoid gestasionis

PV:

Pemphigus vulgaris

PF:

Pemphigus foliaceus

BMZ:

basement membrane zone

AECP:

anti-epiligrin cicatricial pemphigoid

ELISA:

enzyme-linked immunosorbent assay

References

  1. Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study. BMJ. 2008;337:a180.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Marazza G, Pham HC, Schärer L, Pedrazzetti PP, Hunziker T, Trüeb RM, Hohl D, Itin P, Lautenschlager S, Naldi L, Borradori L. Autoimmune bullous disease Swiss study group. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol. 2009;161(4):861–8.

    Article  CAS  PubMed  Google Scholar 

  3. Schmidt E, della Torre R, Borradori L. Clinical features and practical diagnosis of bullous pemphigoid. Dermatol Clin. 2011;29(3):427–38.

    Article  CAS  PubMed  Google Scholar 

  4. Joly P, Baricault S, Sparsa A, Bernard P, Bédane C, Duvert-Lehembre S, Courville P, Bravard P, Rémond B, Doffoel-Hantz V, Bénichou J. Incidence andmortality of bullous pemphigoid in France. J Invest Dermatol. 2012;132(8):1998–2004.

    Article  CAS  PubMed  Google Scholar 

  5. Marazza G, Pham HC, Scharer L, et al. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol. 2009;161:861–8.

    Article  CAS  PubMed  Google Scholar 

  6. Bertram F, Brocker EB, Zillikens D, Schmidt E. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges. 2009;7:434–40.

    PubMed  Google Scholar 

  7. Gudi VS, White MI, Cruickshank N, et al. Annual incidence and mortality of bullous pemphigoid in the Grampian region of north-east Scotland. Br J Dermatol. 2005;153:424–7.

    Article  CAS  PubMed  Google Scholar 

  8. Joly P, Baricault S, Sparsa A, et al. Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol. 2012;132:1998–2004.

    Article  CAS  PubMed  Google Scholar 

  9. Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study. BMJ. 2008;337:160–3.

    Article  Google Scholar 

  10. Jung M, Kippes W, Messer G, Zillikens D, Rzany B. Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol. 1999;41:266–8.

    Article  CAS  PubMed  Google Scholar 

  11. Kulthanan K, Chularojanamontri L, Tuchinda P, Sirikudta W, Pinkaew S. Prevalence and clinical features of Thai patients with bullous pemphigoid. Asian Pac J Allergy Immunol. 2011;29(1):66–72.

    PubMed  Google Scholar 

  12. Kasperkiewicz M, Zillikens D, Schmidt E. Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity. 2012;45(1):55–70.

    Article  CAS  PubMed  Google Scholar 

  13. Sagi L, Baum S, Agmon-Levin N, Sherer Y, Katz BS, Barzilai O, Ram M, Bizzaro N, SanMarco M, Trau H, Shoenfeld Y. Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature. Autoimmun Rev. 2011;10(9):527–35.

    Article  PubMed  Google Scholar 

  14. Le Jan S, Plée J, Vallerand D, Dupont A, Delanez E, Durlach A, Jackson PL, Blalock JE, Bernard P, Antonicelli F. Innate Immune Cell-Produced IL-17 Sustains Inflammation in Bullous Pemphigoid. J Invest Dermatol. 2014;134(12):2908–17.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Diaz LA, Ratrie H 3rd, Saunders WS, et al. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest. 1990;86:1088–94.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol. 1986;136:1231–5.

    CAS  PubMed  Google Scholar 

  17. Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell. 1981;24:897–903.

    Google Scholar 

  18. Knudson RM, Kalaaji AN, Bruce AJ. The management of mucous membrane pemphigoid and pemphigus. Dermatol Ther. 2010;23(3):268–80.

    Article  PubMed  Google Scholar 

  19. Fuchs E, Raghavan S. Getting under the skin of epidermal morphogenesis. Nat Rev Genet. 2002;3(3):199–209. (Review. PubMed PMID: 11972157).

    Article  CAS  PubMed  Google Scholar 

  20. Rzany B, Partscht K, Jung M, et al. Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. Arch Dermatol. 2002;138:903–8.

    Article  PubMed  Google Scholar 

  21. Chen YJ, Wu CY, Lin MW, et al. Comorbidity profi les among patients with bullous pemphigoid: a nationwide population-based study. Br J Dermatol. 2011;165:593–9.

    Article  CAS  PubMed  Google Scholar 

  22. Langan SM, Groves RW, West J. The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. J Invest Dermatol. 2010;131:631–6.

    Article  PubMed  CAS  Google Scholar 

  23. Bastuji-Garin S, Joly P, Lemordant P, et al. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol. 2011;131:637–43.

    Article  CAS  PubMed  Google Scholar 

  24. Seppanen A, Miettinen R, Alafuzoff I. Neuronal collagen XVII is localized to lipofuscin granules. Neuroreport. 2010;21:1090–4.

    Article  PubMed  CAS  Google Scholar 

  25. Claudepierre T, Manglapus MK, Marengi N, et al. Collagen XVII and BPAG1 expression in the retina: evidence for an anchoring complex in the central nervous system. J Comp Neurol. 2005;487:190–203.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Guo L, Degenstein L, Dowling J, Yu QC, Wollmann R, Perman B, Fuchs E. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell. 1995;81:233–43.

    Google Scholar 

  27. Schmidt E, Zillikens D. Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev. 2010;10(2):84–9.

    Article  CAS  PubMed  Google Scholar 

  28. Hofmann S, Thoma-Uszynski S, Hunziker T, Bernard P, Koebnick C, Stauber A, Schuler G, Borradori L, Hertl M. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol. 2002;119:1065–73.

    Google Scholar 

  29. Di Zenzo G, Grosso F, Terracina M, Mariotti F, De Pità O, Owaribe K, Mastrogiacomo A, Sera F, Borradori L, Zambruno G. Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients. J Invest Dermatol. 2004;122(1):103–10.

    Article  PubMed  Google Scholar 

  30. Shirakata Y, Shiraishi S, Sayama K, Miki Y. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus. J Dermatol. 1990;17(11):661–6.

    Article  CAS  PubMed  Google Scholar 

  31. Döpp R, Schmidt E, Chimanovitch I, Leverkus M, Bröcker EB, Zillikens D. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol. 2000;42(4):577–83

    PubMed  Google Scholar 

  32. Woodley DT. The role of IgE anti-basement membrane zone autoantibodies in bullous pemphigoid. Arch Dermatol. 2007;143(2):249–50.

    Article  PubMed  Google Scholar 

  33. Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin Immunol. 2008;128(3):415–26.

    Article  CAS  PubMed  Google Scholar 

  34. Roussel A, Benichou J, Randriamanantany ZA, Gilbert D, Drenovska K, Houivet E, Tron F, Joly P. Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid. Arch Dermatol. 2011;147(3):293–8.

    Article  PubMed  Google Scholar 

  35. Di Zenzo G, Marazza G, Borradori L. Bullous pemphigoid: physiopathology, clinical features and management. Adv Dermatol. 2007;23:257–88.

    Article  PubMed  Google Scholar 

  36. Venning VA, Wojnarowska F. Induced bullous pemphigoid. Br J Dermatol. 1995;132:831–2.

    Article  CAS  PubMed  Google Scholar 

  37. Tosti A, André M, Murrell DF. Nail involvement in autoimmune bullous disorders. Dermatol Clin. 2011;29(3):511–338.

    Article  CAS  PubMed  Google Scholar 

  38. Fleming TE, Korman NJ. Cicatricial pemphigoid. J Am Acad Dermatol. 2000;43(4):571–91. (quiz 591–4)

    Article  CAS  PubMed  Google Scholar 

  39. Gammon WR, Briggaman RA, Inman AO 3rd, Queen LL, Wheeler CE. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol. 1984;82:139–44.

    Article  CAS  PubMed  Google Scholar 

  40. Yoshida M, Hamada T, Amagai M, et al. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci. 2006;41:21–30.

    Article  CAS  PubMed  Google Scholar 

  41. Charneux J, Lorin J, Vitry F, et al. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients. Arch Dermatol. 2011;147:286–91.

    Article  PubMed  Google Scholar 

  42. Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D’Incan M, Plantin P, Bedane C, Young P, Bernard P, Bullous Diseases French Study Group. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346(5):321–7

    Article  CAS  PubMed  Google Scholar 

  43. Guillaume JC, Vaillant L, Bernard P, Picard C, Prost C, Labeille B, Guillot B, Foldès-Pauwels C, Prigent F, Joly P, et al. Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol. 1993;129(1):49–53

    Article  CAS  PubMed  Google Scholar 

  44. Fox JC, Kenkare S, Petronic-Rosic V, Soltani K, Sethi A. Bullous pemphigoid in late childhood successfully treated with mycophenolate mofetil as an adjuvant therapy. Pediatr Dermatol. 2010;27(5):537–9.

    Article  PubMed  Google Scholar 

  45. Du-Thanh A, Merlet S, Maillard H, Bernard P, Joly P, Estève E, Richard MA, Pauwels C, Ingen-Housz-Oro S, Guillot B, Dereure O. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study. Br J Dermatol. 2011;165(6):1337–43.

    Article  CAS  PubMed  Google Scholar 

  46. Kasperkiewicz M, Shimanovich I, Ludwig RJ, Rose C, Zillikens D, Schmidt E. Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients. J Am Acad Dermatol. 2011;65(3):552–8.

    Article  CAS  PubMed  Google Scholar 

  47. Czernik A, Toosi S, Bystryn JC, Grando SA. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update. Autoimmunity. 2012;45(1):111–8.

    Article  CAS  PubMed  Google Scholar 

  48. Schmidt E, Obe K, Bröcker EB, Zillikens D. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol. 2000;136(2):174–8.

    Article  CAS  PubMed  Google Scholar 

  49. Bernard P, Reguiai Z, Tancrède-Bohin E, Cordel N, Plantin P, Pauwels C, Vaillant L, Grange F, Richard-Lallemand MA, Sassolas B, Roujeau JC, Lok C, Picard-Dahan C, Chosidow O, Vitry F, Joly P. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study. Arch Dermatol. 2009;145(5):537–42.

    Article  PubMed  Google Scholar 

  50. Cortés B, Marazza G, Naldi L, Combescure C, Borradori L. Autoimmune Bullous Disease Swiss Study Group. Mortality of bullous pemphigoid in Switzerland: a prospective study. Br J Dermatol. 2011;165(2):368–74.

    Article  PubMed  Google Scholar 

  51. Joly P, Baricault S, Sparsa A, Bernard P, Bédane C, Duvert-Lehembre S, Courville P, Bravard P, Rémond B, Doffoel-Hantz V, Bénichou J. Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol. 2012;132(8):1998–2004.

    Article  CAS  PubMed  Google Scholar 

  52. Bernard P, Vaillant L, Labeille B, et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol. 1995;131:48–52.

    Article  CAS  PubMed  Google Scholar 

  53. Ahmed AR, Kurgis BS, Rogers RS 3rd. Cicatricial pemphigoid. J Am Acad Dermatol. 1991;24:987–1001.

    Article  CAS  PubMed  Google Scholar 

  54. Oyama N, Setterfield JF, Powell AM, Sakuma-Oyama Y, Albert S, Bhogal BS, Vaughan RW, Kaneko F, Challacombe SJ, Black MM. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. Br J Dermatol. 2006;154(1):90–8

    Article  CAS  PubMed  Google Scholar 

  55. Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol. 1995t;105(4):543–8

    Article  CAS  PubMed  Google Scholar 

  56. Kasperkiewicz M, Zillikens D, Schmidt E. Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity. 2012;45(1):55–70.

    Article  CAS  PubMed  Google Scholar 

  57. Yancey KB, Egan CA. Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations. JAMA. 2000;284(3):350–6.

    Article  CAS  PubMed  Google Scholar 

  58. Sagi L, Baum S, Agmon-Levin N, Sherer Y, Katz BS, Barzilai O, Ram M, Bizzaro N, SanMarco M, Trau H, Shoenfeld Y. Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature. Autoimmun Rev. 2011;10(9):527–35.

    Article  PubMed  Google Scholar 

  59. Di Zenzo G, Thoma-Uszynski S, Calabresi V, Fontao L, Hofmann SC, Lacour JP, Sera F, Bruckner-Tuderman L, Zambruno G, Borradori L, Hertl M. Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study. J Invest Dermatol. 2011;131(11):2271–80.

    Article  CAS  PubMed  Google Scholar 

  60. Schmidt E, Zillikens D. Pemphigoid disease. Lancet. 2013;381:320–32.

    Article  PubMed  Google Scholar 

  61. Lazarova Z, Yancey KB. Cicatricial pemphigoid: immunopathogenesis and treatment Prognosis. Dermatologic Therapy. 2002;15:382.

    Article  Google Scholar 

  62. Assmann T, Becker J, Ruzicka T, Megahed M. Topical tacrolimus for oral cicatricial pemphigoid. Clin Exp Dermatol. 2004;29(6):674–6.

    Article  CAS  PubMed  Google Scholar 

  63. Kourosh AS, Yancey KB. Therapeutic approaches to patients with mucous membrane pemphigoid. Dermatol Clin. 2011;29(4):637–41.

    Article  CAS  PubMed  Google Scholar 

  64. Segura S, Iranzo P, Martínez-de Pablo I, Mascaró JM Jr, Alsina M, Herrero J, Herrero C. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases. J Am Acad Dermatol. 2007;56(6):960–7.

    Article  PubMed  Google Scholar 

  65. Ambros-Rudolph CM, Mullegger RR, Vaughan-Jones SA, Kerl H, Black MM. The specific dermatoses of pregnancy revisited and reclassifi ed: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol. 2006;54:395–404.

    Article  PubMed  Google Scholar 

  66. Shimanovich I, Bröcker EB, Zillikens D. Pemphigoid gestationis: new insights into the pathogenesis lead to novel diagnostic tools. BJOG. 2002;109(9):970–6.

    Article  PubMed  Google Scholar 

  67. Roger D, Vaillant L, Fignon A, Pierre F, Bacq Y, Brechot JF, Grangeponte MC, Lorette G. Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women. Arch Dermatol. 1994;130(6):734–9

    Article  CAS  PubMed  Google Scholar 

  68. Chimanovitch I, Schmidt E, Messer G, et al. IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16A domain of BP180 in pemphigoid gestationis. J Invest Dermatol. 1999;113:140–2.

    Article  CAS  PubMed  Google Scholar 

  69. Chi CC, Wang SH, Charles-Holmes R, et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol. 2009;160:1222–8.

    Article  PubMed  Google Scholar 

  70. Jenkins RE, Hern S, Black MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol. 1999;24:255–9.

    Article  CAS  PubMed  Google Scholar 

  71. Jenkins RE, Shornick JK, Black BL. Pemphigoid gestationis. J Eur Acad Dermatol Venereol. 1993;2:163.

    Article  Google Scholar 

  72. Fortuna G, Marinkovich MP. Linear immunoglobulin a bullous dermatosis. Clin Dermatol. 2012;30(1):38–50.

    Article  PubMed  Google Scholar 

  73. Marinkovich MP, Taylor TB, Keene DR, Burgeson RE, Zone JJ. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring fi lament protein synthesized by epidermal cells. J Invest Dermatol. 1996;106:734–38.

    Article  CAS  PubMed  Google Scholar 

  74. Collier PM, Wojnarowska F, Welsh K, McGuire W, Black MM. Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression. Br J Dermatol. 1999;141(5):867–75.

    Article  CAS  PubMed  Google Scholar 

  75. Paige DG, Leonard JN, Wojnarowska F, Fry L. Linear IgA disease and ulcerative colitis. Br J Dermatol. 1997;136(5):779–82.

    Article  CAS  PubMed  Google Scholar 

  76. Guide SV, Marinkovich MP. Linear IgA bullous dermatosis. Clin Dermatol. 2001;19(6):719–27.

    Article  CAS  PubMed  Google Scholar 

  77. Ng SY, Venning VV. Management of linear IgA disease. Dermatol Clin. 2011;29:629–30.

    Article  CAS  PubMed  Google Scholar 

  78. Aram H. Linear IgA bullous dermatosis. Successful treatment with colchicine. Arch Dermatol. 1984;120(7):960–1.

    Article  CAS  PubMed  Google Scholar 

  79. Wong SN, Chua SH. Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review. Br J Dermatol. 2002;147:476–80.

    Article  CAS  PubMed  Google Scholar 

  80. Hirose M, Vafia K, Kalies K, et al. Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen. J Autoimmun. 2012;39:304–14

    Article  CAS  PubMed  Google Scholar 

  81. Gammon WR, Heise ER, Burke WA, Fine JD, Woodley DT, Briggaman RA. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol. 1988;91(3):228–32.

    Article  CAS  PubMed  Google Scholar 

  82. Chen M, Kim GH, Prakash L, Woodley DT. Epidermolysis bullosa acquisita: autoimmunity to anchoring fi bril collagen. Autoimmunity. 2012;45:91–101.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  83. Thiers BH. Pemphigus. J Am Acad Dermatol. 1981;4:603–5.

    Google Scholar 

  84. Ruocco V, Ruocco E, Lo Schiavo A, Brunetti G, Guerrera LP, Wolf R. Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies. Clin Dermatol. 2013;31:374–81.

    Article  PubMed  Google Scholar 

  85. Scully C, Challacombe SJ. Pemphigus vulgaris: update on etiopathogenesis, oral manifestations, and management. Crit Rev Oral Biol Med. 2002;13:397–408.

    Article  PubMed  Google Scholar 

  86. Baum S, Sakka N, Artsi O, Trau H, Barzilai A. Diagnosis and classification of autoimmune blistering diseases. Autoimmun Rev. 2014;13:482–9.

    Article  CAS  PubMed  Google Scholar 

  87. Kershenovich R, Hodak E, Mimouni D. Diagnosis and classification of pemphigus and bullous pemphigoid. Autoimmun Rev. 2014;13:477–81.

    Article  CAS  PubMed  Google Scholar 

  88. Santoro FA, Stoopler ET, Werth VP. Pemphigus. Dent Clin North Am. 2013;57:597–610.

    Article  PubMed  Google Scholar 

  89. Hertl M, Veldman C. Pemphigus—paradigm of autoantibody-mediated autoimmunity. Skin Pharmacol Appl Skin Physiol. 2001;14:408–18.

    Google Scholar 

  90. Bickle K, Roark TR, Hsu S. Autoimmune bullous dermatoses: a review. Am Fam Physician. 2002;65:1861–70.

    PubMed  Google Scholar 

  91. Ruocco E, Baroni A, Wolf R, Ruocco V. Life-threatening bullous dermatoses: pemphigus vulgaris. Clin Dermatol. 2005;23:223–6.

    Article  PubMed  Google Scholar 

  92. Tron F, Gilbert D, Mouquet H, Joly P, Drouot L, Makni S, Masmoudi H, Charron D, Zitouni M, Loiseau P, Ben Ayed M. Genetic factors in pemphigus. J Autoimmun. 2005;24:319–28.

    Article  CAS  PubMed  Google Scholar 

  93. Gazit E, Loewenthal R. The immunogenetics of pemphigus vulgaris. Autoimmun Rev. 2005;4:16–20.

    Article  CAS  PubMed  Google Scholar 

  94. Bystryn JC, Rudolph JL. Pemphigus. Lancet. 2005;366:61–73.

    Article  PubMed  Google Scholar 

  95. Grando SA. Pemphigus autoimmunity: hypotheses and realities. Autoimmunity. 2012;45:7–35.

    Article  CAS  PubMed  Google Scholar 

  96. Tron F, Gilbert D, Joly P, Mouquet H, Drouot L, Ayed MB, Sellami M, Masmoudi H, Makni S. Immunogenetics of pemphigus: an update. Autoimmunity. 2006;39:531–9.

    Article  CAS  PubMed  Google Scholar 

  97. Uzun S, Durdu M. The specificity and sensitivity of Nikolskiy sign in the diagnosis of pemphigus. J Am Acad Dermatol. 2006;54:411–5.

    Article  PubMed  Google Scholar 

  98. Becker BA, Gaspari AA. Pemphigus vulgaris and vegetans. Dermatol Clin. 1993;11:429–52.

    CAS  PubMed  Google Scholar 

  99. James KA, Culton DA, Diaz LA. Diagnosis & clinical features of pemphigus foliaceus. Dermatol Clin 2011;29:405–12.

    Google Scholar 

  100. Pérez-Pérez ME, Avalos-Díaz E, Herrera-Esparza R. Autoantibodies in senear-usher syndrome: cross-reactivity or multiple autoimmunity? Autoimmune Dis. 2012;2012:296214.

    PubMed Central  PubMed  Google Scholar 

  101. Porro AM, Caetano Lde V, Maehara Lde S, Enokihara MM. Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus. An Bras Dermatol. 2014;89:96–106.

    Article  PubMed Central  PubMed  Google Scholar 

  102. Hashimoto T. Immunopathology of IgA pemphigus. Clin Dermatol. 2001;19:683–9.

    Article  CAS  PubMed  Google Scholar 

  103. Beutner EH, Chorzelski TP, Wilson RM, Kumar V, Michel B, Helm F, Jablonska S. IgA pemphigus foliaceus. Report of two cases and a review of the literature. J Am Acad Dermatol. 1989;20:89–97.

    Article  CAS  PubMed  Google Scholar 

  104. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H 3rd, Mutasim D, Ariss-Abdo L. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990;323:1729–35.

    Article  CAS  PubMed  Google Scholar 

  105. Frew JW, Murrell DF. Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis. Dermatol Clin. 2011;29:419–25.

    Article  CAS  PubMed  Google Scholar 

  106. Zimmermann J, Bahmer F, Rose C, Zillikens D, Schmidt E. Clinical and immunopathological spectrum of paraneoplastic pemphigus. J Dtsch Dermatol Ges. 2010;8:598–606.

    PubMed  Google Scholar 

  107. Nguyen VT, Ndoye A, Bassler KD, Shultz LD, Shields MC, Ruben BS, Webber RJ, Pittelkow MR, Lynch PJ, Grando SA. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol. 2001;137:193–206.

    CAS  PubMed  Google Scholar 

  108. Horn TD, Anhalt GJ. Histologic features of paraneoplastic pemphigus. Arch Dermatol. 1992;128:1091–5.

    Article  CAS  PubMed  Google Scholar 

  109. Robinson ND, Hashimoto T, Amagai M, Chan LS. The new pemphigus variants. J Am Acad Dermatol. 1999;40:649–71.

    Article  CAS  PubMed  Google Scholar 

  110. Santi CG, Maruta CW, Aoki V, Sotto MN, Rivitti EA, Diaz LA. Pemphigus herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus, fogo selvagem, and pemphigus vulgaris. Cooperative Group on Fogo Selvagem Research. J Am Acad Dermatol. 1996;34:40–6.

    Article  CAS  PubMed  Google Scholar 

  111. Prado R, Brice SL, Fukuda S, Hashimoto T, Fujita M. Paraneoplastic pemphigus herpetiformis with IgG antibodies to desmoglein 3 and without mucosal lesions. Arch Dermatol. 2011;147:67–71.

    Article  PubMed  Google Scholar 

  112. Schmidt E, Zillikens D. The diagnosis and treatment of autoimmune blistering skin diseases. Dtsch Ärztebl Int 2011;108:399–405.

    PubMed Central  PubMed  Google Scholar 

  113. Daniel BS, Murrell DF. Management of pemphigus. F1000Prime Rep. 2014;6:32.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  114. Hooten JN, Hall RP, Cardones AR. Updates on the management of autoimmune blistering diseases. Skin Therapy Lett. 2014;19:1–6.

    PubMed  Google Scholar 

  115. Atzmony L, Hodak E, Gdalevich M, Rosenbaum O, Mimouni D. Treatment of pemphigus vulgaris and pemphigus foliaceus: a systematic review and meta-analysis. Am J Clin Dermatol. 2014;15:503–15.

    Article  PubMed  Google Scholar 

  116. Singh S. Evidence-based treatments for pemphigus vulgaris, pemphigus foliaceus, and bullous pemphigoid: a systematic review. Indian J Dermatol Venereol Leprol. 2011;77:456–69.

    Article  PubMed  Google Scholar 

  117. Gürcan H, Mabrouk D, Razzaque AA. Management of pemphigus in pediatric patients. Minerva Pediatr. 2011;63:279–91.

    PubMed  Google Scholar 

  118. Leventhal JS, Sanchez MR. Is it time to re-evaluate the treatment of pemphigus? J Drugs Dermatol. 2012;11:1200–6.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for blistering diseases, 697 Cambridge street, suite 302, 02135, Boston, MA, USA

    Raman Mehrzad MD, Shawn Shetty MD & A. Razzaque Ahmed MD, DSc, MPA

Authors
  1. Raman Mehrzad MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shawn Shetty MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Razzaque Ahmed MD, DSc, MPA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Razzaque Ahmed MD, DSc, MPA .

Editor information

Editors and Affiliations

  1. Brigham and Women’s Hospital, Boston, Massachusetts, USA

    Stephen T. Sonis, DMD, DMSc

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Mehrzad, R., Shetty, S., Ahmed, A. (2015). Blistering Diseases – Pemphigoid. In: Sonis, DMD, DMSc, S. (eds) Genomics, Personalized Medicine and Oral Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-17942-1_10

Download citation

Publish with us

Policies and ethics

Search

Navigation